Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
Anticancer Res. 2024 Nov;44(11):4709-4721. doi: 10.21873/anticanres.17297.
BACKGROUND/AIM: The severe malignancy of pancreatic ductal adenocarcinoma (PDAC) is mainly due to frequent local invasiveness and distant metastasis. As for local invasiveness, we previously reported that cancer-specific molecular alterations detected on resected PDAC specimen surfaces, so-called molecular surgical margin (MSM) positiveness, were significantly associated with postoperative locoregional recurrence and distant metastasis. However, due to anatomical limitations, achieving adequate surgical margins during pancreatic cancer resection is often challenging. Therefore, predicting local invasiveness based on the primary tumor's gene profile is crucial to avoid positive MSM.
Genome-wide miRNA expression profiles were examined and compared between MSM-positive and negative cases. Candidate miRNAs were evaluated in another validation cohort, and their clinicopathological characteristics were examined. Mimic or inhibitor constructs of the candidate miRNA were transfected to PDAC cell lines to evaluate the miRNA function in the pancreatic cancer cell lines and detect the downstream targets.
Among some candidates with highly expressed miRNAs in MSM-positive cases by miRNA expression array, recurrence-free survival (RFS) was significantly shorter in the miR-210-3p high expression group (p=0.015). High miR-210-3p was significantly associated with large tumor diameter (p=0.001), anterior invasion positive (p=0.010), and positive lymph node metastasis (p<0.001). miR-210-3p inhibition in PDAC cell lines resulted in decreased proliferation and invasiveness. The iron-sulfur cluster assembly enzyme (ISCU) gene was identified as a target of miR-210-3p. ISCU reduction was significantly observed in PDAC primary tumors with high levels of miR-210-3p, leading to mitochondrial dysfunction in miR-210-3p-overexpressing PDAC cell lines, as demonstrated by glycolysis stress tests.
Highly expressed hypoxia-inducible miR-210-3p in primary PDAC tissues induces locally invasive characteristics through mitochondrial dysfunction by suppressing ISCU expression, which may result in poor postoperative RFS outcomes.
背景/目的:胰腺导管腺癌(PDAC)的严重恶性程度主要归因于频繁的局部侵袭和远处转移。对于局部侵袭,我们之前报道过,在切除的 PDAC 标本表面检测到的癌症特异性分子改变,即所谓的分子手术切缘(MSM)阳性,与术后局部区域复发和远处转移显著相关。然而,由于解剖学限制,在胰腺癌切除术中获得足够的手术切缘往往具有挑战性。因此,基于原发性肿瘤的基因谱预测局部侵袭性对于避免 MSM 阳性至关重要。
对 MSM 阳性和阴性病例进行全基因组 miRNA 表达谱分析和比较。在另一个验证队列中评估候选 miRNA,并检查其临床病理特征。将候选 miRNA 的模拟物或抑制剂构建体转染至 PDAC 细胞系,以评估 miRNA 在胰腺癌细胞系中的功能,并检测下游靶标。
在 miRNA 表达谱阵列中,MSM 阳性病例中某些高表达 miRNA 的候选物中,miR-210-3p 高表达组的无复发生存期(RFS)显著缩短(p=0.015)。高 miR-210-3p 与大肿瘤直径显著相关(p=0.001)、前方侵袭阳性(p=0.010)和阳性淋巴结转移相关(p<0.001)。PDAC 细胞系中 miR-210-3p 的抑制导致增殖和侵袭性降低。铁硫簇装配酶(ISCU)基因被鉴定为 miR-210-3p 的靶标。在 miR-210-3p 高表达的 PDAC 原发性肿瘤中观察到 ISCU 减少,导致 miR-210-3p 过表达的 PDAC 细胞系中线粒体功能障碍,通过糖酵解应激试验证实。
在原发性 PDAC 组织中高表达的缺氧诱导 miR-210-3p 通过抑制 ISCU 表达诱导局部侵袭特征,从而导致不良的术后 RFS 结果。